# WisdomTree BioRevolution UCITS ETF AccumUSD (WBIO) **Page:** https://fundology.uk/fund/wbio · ISIN IE000O8KMPM1 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, WBIO (WisdomTree BioRevolution UCITS ETF AccumUSD, ISIN IE000O8KMPM1) closed at £19.12 on the London Stock Exchange. Its ongoing charge is 0.45% a year (about £45 on £10,000). Over the three years to 13/11/2026 its total return was +63.8%, or +48.0% after UK CPIH inflation. ## Summary WisdomTree BioRevolution UCITS ETF AccumUSD is an exchange-traded fund (ETF) from WisdomTree, launched in 2021. It tracks the WisdomTree Battery Solutions Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.45% a year — about £45 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£19.12** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | WBIO | | ISIN | IE000O8KMPM1 | | Also listed as | WDNA (London Stock Exchange, US dollars), WRNA (Xetra, euros) | | Category | Single sectors | | Type | ETF | | Provider | WisdomTree | | Tracks | WisdomTree Battery Solutions Index | | Income | Accumulating | | Ongoing charge | 0.45% a year (£45 per £10,000) | | Fund size | £40.9m | | Launched | 2021 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 21/10/2021 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +45.04% | +39.90% | income reinvested | | 3 years | +63.83% | +48.02% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of WisdomTree BioRevolution UCITS ETF AccumUSD in pounds (price, with income reinvested in the fund): 2022 −18.2%, 2023 −5.9%, 2024 −12.1%, 2025 +10.8%; 2026 to 13/11/2026 +35.2%. Returns of WisdomTree BioRevolution UCITS ETF AccumUSD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +49.6%; to 30/09/2025: +2.2%; to 30/09/2024: +0.4%; to 30/09/2023: −19.5%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | -18.2% | -25.2% | Price | | 2023 | -5.9% | -9.6% | Price | | 2024 | -12.1% | -15.1% | Price | | 2025 | +10.8% | +7.0% | Price | | 2026 to 13/11/2026 | +35.2% | +30.9% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 26.05% | -9.18% | | 3 years | 24.89% | -35.86% | ## Largest fall Volatility of WisdomTree BioRevolution UCITS ETF AccumUSD in pounds, annualised from weekly returns to 13/11/2026: 26.0% over 1 year, 24.9% over 3 years. Largest fall in the price of WisdomTree BioRevolution UCITS ETF AccumUSD since December 2021, in pounds: −49.4% from 24/12/2021 to 11/04/2025. The lowest 12-month return of WisdomTree BioRevolution UCITS ETF AccumUSD in pounds (price, with income reinvested in the fund) since December 2021 was −30.1% (12 months to 11/04/2025); the highest was +70.5% (12 months to 28/08/2026). On 13/11/2026 the price of WisdomTree BioRevolution UCITS ETF AccumUSD was 5.6% below its highest weekly close since December 2021 (30/10/2026), in pounds. ## Charges compared with similar funds Ongoing charge of WisdomTree BioRevolution UCITS ETF AccumUSD 0.45% a year. Compared on 14/11/2026, 61 of the 164 other single-sector funds charge more, 2 the same and 101 less (share classes counted once). ## Funds tracking the same index 2 funds track WisdomTree Battery Solutions Index, this one included and share classes counted once; their ongoing charges range from 0.40% to 0.45% a year (13/11/2026). | Fund | Ongoing charge | 1 year | 3 years | 5 years | |---|---|---|---|---| | WisdomTree Battery Solutions UCITS ETF USD Acc | 0.40% | -13.8% | +28.2% | — | | WisdomTree BioRevolution UCITS ETF AccumUSD (this fund) | 0.45% | +45.0% | +63.8% | — | Returns are as reported, in pounds, income reinvested unless marked "(price)". ## Charges & eligibility - Ongoing charges figure (OCF): **0.45%** per year - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## Questions people ask **What is the ongoing charge of WBIO?** The ongoing charge of WBIO is 0.45% a year — about £45 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of WisdomTree BioRevolution UCITS ETF AccumUSD 0.45% a year. Compared on 14/11/2026, 61 of the 164 other single-sector funds charge more, 2 the same and 101 less (share classes counted once). **What does WBIO track?** WBIO tracks the WisdomTree Battery Solutions Index. **Is WBIO accumulating or distributing?** WBIO is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of WBIO?** The ISIN of WBIO is IE000O8KMPM1. An ISIN identifies one exact share class of a fund; WBIO is its ticker on the London Stock Exchange. The same share class is also listed as WDNA (London Stock Exchange, US dollars) and WRNA (Xetra, euros). **What were WBIO’s returns in each of the last five years?** Calendar-year returns of WBIO in pounds (price, with income reinvested in the fund): 2022 −18.2%, 2023 −5.9%, 2024 −12.1%, 2025 +10.8%; 2026 to 13/11/2026 +35.2%. Past performance is not a guide to future returns. **How has WBIO done after inflation?** Over the three years to 13/11/2026 WBIO’s total return was +63.8%, or +48.0% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.